{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:15:39Z","timestamp":1784834139363,"version":"3.55.0"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","funder":[{"name":"National Institute of Child Health and Human Development","award":["K12HD103083"],"award-info":[{"award-number":["K12HD103083"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To systematically review and meta-analyze alloimmunization among recipients of red blood cells (RBCs) matched for ABO blood type and Rhesus D (ABO+D) antigen compared with those also matched for c, E, and Kell (cEK).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SOURCES:<\/jats:title>\n            <jats:p>Four online databases (Medline, Scopus, EMBASE, ClinicalTrials.gov) were searched from March 28, 2023, to April 1, 2024. The search protocol was peer reviewed and published on PROSPERO (CRD42023411620).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS OF STUDY SELECTION:<\/jats:title>\n            <jats:p>Studies reporting alloimmunization as the primary outcome among recipients of RBCs matched for ABO+D or additional cEK matching were included. Patients transfused with unmatched RBCs or a mixture of matching regimens were excluded. Risk of bias was assessed with Cochrane Tool to Assess Risk of Bias in Cohort Studies and Tool for Risk of Bias. Random-effects meta-analysis was used to combine effect estimates.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>TABULATION, INTEGRATION, AND RESULTS:<\/jats:title>\n            <jats:p>Ten studies met criteria. Risk of bias was low. Overall, 91,221 patients were transfused, of whom 40,220 (44.1%) received additional cEK-matched RBCs. The overall rate of alloimmunization was 6.2% (95% CI, 2.5\u201314.9%) for ABO+D\u2013only matching and 1.9% (95% CI, 0.7\u20135.1%) when cEK was added. Time of follow-up antibody testing ranged from 6 to 18 months after transfusion. Additional cEK match was associated with significantly less alloimmunization compared with standard ABO+D match (odds ratio [OR] 0.37, 95% CI, 0.20\u20130.69). This association remained when chronically transfused patients were excluded (OR 0.65, 95% CI, 0.54\u20130.79) and for alloimmunization to c, E, or K antigens only (OR 0.29, 95% CI, 0.18\u20130.47).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Additional cEK RBC matching protocols were associated with lower odds of recipient alloimmunization. Given severe sequelae of alloimmunization in pregnancy, routine cEK matching for transfusion in people with pregnancy potential younger than age 50 years in the United States merits consideration.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SYSTEMATIC REVIEW REGISTRATION:<\/jats:title>\n            <jats:p>PROSPERO, CRD42023411620.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000005701","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T22:57:34Z","timestamp":1723157854000},"page":"444-453","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Standard Compared With Extended Red Blood Cell Antigen Matching for Prevention of Subsequent Hemolytic Disease of the Fetus and Newborn"],"prefix":"10.1097","volume":"144","author":[{"given":"Ronan P.","family":"Sugrue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaxon","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Elise","family":"Abi Antoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley A.","family":"Skalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Cate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andra H.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Stonehill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn J.","family":"Telen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome J.","family":"Federspiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,8,8]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1053\/j.seminhematol.2005.04.007","article-title":"Red blood cell alloimmunization in pregnancy","volume":"42","author":"Moise","year":"2005","journal-title":"Semin Hematol"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1182\/bloodadvances.2022006982","article-title":"Red cell alloimmunization is associated with increased health care costs, longer hospitalizations, and higher mortality","volume":"6","author":"Viayna","year":"2022","journal-title":"Blood Adv"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1111\/trf.14262","article-title":"Red blood cell alloimmunization in pregnancy during the years 1996\u20102015 in Iceland: a nation\u2010wide population study","volume":"57","author":"Bollason","year":"2017","journal-title":"Transfusion"},{"key":"R4-20250502","first-page":"1","article-title":"Prevalence of red blood cell alloantibodies in pregnant women and hemolytic disease of newborn in a tertiary care hospital","volume":"2","author":"Solves","year":"2017","journal-title":"ARC J Gynecol Obstet"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/tme.12511","article-title":"RBC alloantibody prevalence and specificity in a western Norwegian tertiary hospital","volume":"29","author":"Erikstein","year":"2019","journal-title":"Transfus Med"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/PAT.0000000000000225","article-title":"Prevalence of maternal red cell alloimmunisation: a population study from Queensland, Australia","volume":"47","author":"Pal","year":"2015","journal-title":"Pathology"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1365-3148.2003.00445.x","article-title":"Prevalence and specificity of clinically significant red cell alloantibodies in Chinese women during pregnancy\u2014a review of cases from 1997 to 2001","volume":"13","author":"Lee","year":"2003","journal-title":"Transfus Med"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S1701-2163(15)30148-1","article-title":"Alloimmune red blood cell antibodies: prevalence and pathogenicity in a Canadian prenatal population","volume":"37","author":"Zwingerman","year":"2015","journal-title":"J Obstet Gynaecol Can"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2147\/JBM.S214118","article-title":"Prevalence and specificity of clinically significant red cell alloantibodies in pregnant women\u2014a study from a tertiary care hospital in southeast Michigan","volume":"10","author":"Moinuddin","year":"2019","journal-title":"J Blood Med"},{"key":"R10-20250502","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2023012241","article-title":"Maternal red blood cell alloimmunization prevalence in the United States","author":"Sugrue","year":"2024","journal-title":"Blood Adv."},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"127","DOI":"10.21307\/immunohematology-2019-134","article-title":"Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility","volume":"29","author":"Smith","year":"2013","journal-title":"Immunohematology"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/bjh.14438","article-title":"Antigen specificity determines anti\u2010red blood cell IgG\u2010Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn","volume":"176","author":"Sonneveld","year":"2017","journal-title":"Br J Haematol"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/j.1537-2995.2010.03006.x","article-title":"Severe hemolytic disease of fetus and newborn caused by red blood cell antibodies undetected at first\u2010trimester screening (CME)","volume":"51","author":"Dajak","year":"2011","journal-title":"Transfusion"},{"key":"R14-20250502","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000020.pub3","article-title":"Anti\u2010D administration in pregnancy for preventing Rhesus alloimmunisation","author":"McBain","year":"2015","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/tme.12099","article-title":"Anti\u2010D prophylaxis: past, present and future","volume":"24","author":"De Haas","year":"2014","journal-title":"Transfus Med"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1471-0528.2008.01984.x","article-title":"Risk factors for the presence of non\u2010rhesus D red blood cell antibodies in pregnancy","volume":"116","author":"Koelewijn","year":"2009","journal-title":"BJOG"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1046\/j.1537-2995.2001.41091086.x","article-title":"Prospective RBC phenotype matching in a stroke\u2010prevention trial in sickle cell anemia: a multicenter transfusion trial","volume":"41","author":"Vichinsky","year":"2001","journal-title":"Transfusion"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/j.1537-2995.2010.03045.x","article-title":"Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14\u2010year experience from a single center (CME)","volume":"51","author":"LaSalle\u2010Williams","year":"2011","journal-title":"Transfusion"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.hoc.2016.01.011","article-title":"Management of patients with sickle cell disease using transfusion therapy: guidelines and complications","volume":"30","author":"Chou","year":"2016","journal-title":"Hematol Oncol Clin North Am"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1537-2995.2006.00708.x","article-title":"Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity","volume":"46","author":"Schonewille","year":"2006","journal-title":"Transfusion"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1590\/S0100-879X2005000500004","article-title":"Risk factors for alloimmunization by patients with sickle cell disease","volume":"38","author":"Murao","year":"2005","journal-title":"Braz J Med Biol Res"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1111\/aogs.14261","article-title":"Management and clinical consequences of red blood cell antibodies in pregnancy: a population-based cohort study","volume":"100","author":"Liu","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1537-2995.2007.01625.x","article-title":"Effect of screening for red cell antibodies, other than anti\u2010D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands","volume":"48","author":"Koelewijn","year":"2008","journal-title":"Transfusion"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-3148.2012.01199.x","article-title":"Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories: British Committee for Standards in Haematology","volume":"23","author":"Milkins","year":"2013","journal-title":"Transfus Med"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1016\/S2352-3026(16)30043-6","article-title":"Red cell alloimmunisation: incidence and prevention","volume":"3","author":"Flegel","year":"2016","journal-title":"Lancet Haematol"},{"key":"R29-20250502","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/jamasurg.2021.0522","article-title":"MOOSE reporting guidelines for meta-analyses of observational studies","volume":"156","author":"Brooke","year":"2021","journal-title":"JAMA Surg"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R31-20250502","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2046-4053-1-2","article-title":"The nuts and bolts of PROSPERO: an international prospective register of systematic reviews","volume":"1","author":"Booth","year":"2012","journal-title":"Syst Rev"},{"key":"R32-20250502","doi-asserted-by":"crossref","DOI":"10.3791\/58494","article-title":"Comparing bibliometric analysis using PubMed, Scopus, and Web of Science databases","author":"AlRyalat","year":"2019","journal-title":"J Vis Exp."},{"key":"R33-20250502","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.MR000041.pub2","article-title":"Search strategies to identify observational studies in MEDLINE and Embase","author":"Li","year":"2019","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R34-20250502","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS peer review of electronic search strategies: 2015 guideline statement","volume":"75","author":"McGowan","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"R35-20250502","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/trf.13977","article-title":"Blood group antigen matching influence on gestational outcomes (AMIGO) study","volume":"57","author":"Delaney","year":"2017","journal-title":"Transfusion"},{"key":"R36-20250502","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"R37-20250502","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R38-20250502","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/EDE.0000000000001232","article-title":"Meta-analysis of proportions using generalized linear mixed models","volume":"31","author":"Lin","year":"2020","journal-title":"Epidemiology"},{"key":"R39-20250502","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2307\/1267913","article-title":"Restricted maximum likelihood (REML) estimation of variance components in the mixed model","volume":"18","author":"Corbeil","year":"1976","journal-title":"Technometrics"},{"key":"R40-20250502","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/bjh.17697","article-title":"The effect of extended c, E and K matching in females under 45 years of age on the incidence of transfusion-induced red blood cell alloimmunisation","volume":"195","author":"Oud","year":"2021","journal-title":"Br J Haematol"},{"key":"R41-20250502","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/trf.16276","article-title":"Reduction of anti\u2010K\u2010mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: a nation\u2010wide policy change evaluation study in the Netherlands","volume":"61","author":"Luken","year":"2021","journal-title":"Transfusion"},{"key":"R42-20250502","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.transci.2018.11.006","article-title":"Clinical outcome of transfusions with extended red blood cell matching in \u03b2-thalassemia patients: a single-center experience","volume":"58","author":"Belsito","year":"2019","journal-title":"Transfus Apher Sci"},{"key":"R43-20250502","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/trf.15002","article-title":"The prevalence, alloimmunization risk factors, antigenic exposure, and evaluation of antigen-matched red blood cells for thalassemia transfusions: a 10-year experience at a tertiary care hospital","volume":"59","author":"Romphruk","year":"2019","journal-title":"Transfusion"},{"key":"R44-20250502","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1111\/j.1537-2995.2009.02185.x","article-title":"Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion","volume":"49","author":"Ameen","year":"2009","journal-title":"Transfusion"},{"key":"R45-20250502","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/tme.12271","article-title":"Phenotyping Rh\/Kell and risk of alloimmunization in haematological patients","volume":"26","author":"Ba\u00eda","year":"2016","journal-title":"Transfus Med"},{"key":"R46-20250502","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/trf.13608","article-title":"Red blood cell alloimmunization in transfused patients with bone marrow failure syndromes","volume":"56","author":"Cohen","year":"2016","journal-title":"Transfusion"},{"key":"R47-20250502","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/vox.12914","article-title":"Red-blood-cell alloimmunization and prophylactic antigen matching for transfusion in patients with warm autoantibodies","volume":"115","author":"Delaney","year":"2020","journal-title":"Vox Sang"},{"key":"R48-20250502","first-page":"363","article-title":"Red cell alloantibodies in patients with haemoglobinopathies","volume":"36","author":"Hmida","year":"1994","journal-title":"Nouv Rev Fr Hematol (1978)"},{"key":"R49-20250502","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/vox.12455","article-title":"Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion\u2010dependent patients with myelodysplastic syndromes","volume":"112","author":"Lin","year":"2017","journal-title":"Vox Sang"},{"issue":"suppl 1","key":"R50-20250502","first-page":"s100","article-title":"Alloimmunisation in thalassaemics: a comparison between recipients of usual matched and partial better matched blood: an evaluation at a tertiary care centre in India","volume":"12","author":"Pujani","year":"2014","journal-title":"Blood Transfus"},{"key":"R51-20250502","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/trf.13347","article-title":"Incidence of alloantibody formation after ABO\u2010D or extended matched red blood cell transfusions: a randomized trial (MATCH study)","volume":"56","author":"Schonewille","year":"2016","journal-title":"Transfusion"},{"key":"R52-20250502","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3889\/oamjms.2017.054","article-title":"The impact of extended typing on red blood cell alloimmunization in transfused patients","volume":"5","author":"Makarovska-Bojadzieva","year":"2017","journal-title":"Open Access Maced J Med Sci"},{"key":"R55-20250502","doi-asserted-by":"crossref","first-page":"206","DOI":"10.5581\/1516-8484.20120051","article-title":"Alloimmunization screening after transfusion of red blood cells in a prospective study","volume":"34","author":"Alves","year":"2012","journal-title":"Rev Brasil Hematol Hemoter"},{"key":"R56-20250502","doi-asserted-by":"crossref","first-page":"113454","DOI":"10.1016\/j.socscimed.2020.113454","article-title":"Health insurance as a state institution: the effect of single-payer insurance on expenditures in OECD countries","volume":"265","author":"Bichay","year":"2020","journal-title":"Soc Sci Med"},{"key":"R58-20250502","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1111\/j.1537-2995.2009.02275.x","article-title":"Red blood cell hemolysis during blood bank storage: using national quality management data to answer basic scientific questions","volume":"49","author":"Hess","year":"2009","journal-title":"Transfusion"},{"key":"R59-20250502","first-page":"164","article-title":"The effectiveness of KEL and RHCE fetal genotype assessment in alloimmunized women by minisequencing","volume":"85","author":"Durdov\u00e1","year":"2020","journal-title":"Ceska Gynekol"},{"key":"R60-20250502","doi-asserted-by":"crossref","first-page":"103759","DOI":"10.1016\/j.ebiom.2021.103759","article-title":"RBCeq: a robust and scalable algorithm for accurate genetic blood typing","volume":"76","author":"Jadhao","year":"2022","journal-title":"EBioMedicine"},{"key":"R62-20250502","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000446043","article-title":"Cross-sectional guidelines for therapy with blood components and plasma derivatives: chapter 5 human albumin\u2014revised","volume":"43","year":"2016","journal-title":"Transfus Med Hemother"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005701","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:44Z","timestamp":1746230444000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005701"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2024,8,8]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005701","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,8]]},"assertion":[{"value":"2024-05-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}